OppenheimerFunds’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$11.5M Buy
88,460
+68,180
+336% +$8.29M 0.01% 652
2018
Q4
$2.35M Sell
20,280
-11,859
-37% -$1.32M ﹤0.01% 838
2018
Q3
$3.45M Sell
32,139
-5,222
-14% -$522K ﹤0.01% 824
2018
Q2
$3.19M Buy
37,361
+10,177
+37% +$836K ﹤0.01% 833
2018
Q1
$2.1M Sell
27,184
-16,515
-38% -$1.33M ﹤0.01% 860
2017
Q4
$3.69M Buy
43,699
+3,257
+8% +$277K ﹤0.01% 832
2017
Q3
$3.46M Buy
40,442
+3,611
+10% +$296K ﹤0.01% 845
2017
Q2
$3.03M Buy
36,831
+3,882
+12% +$317K ﹤0.01% 856
2017
Q1
$2.77M Sell
32,949
-1,777
-5% -$142K ﹤0.01% 888
2016
Q4
$2.55M Sell
34,726
-634,639
-95% -$47.3M ﹤0.01% 891
2016
Q3
$53.7M Buy
669,365
+35,199
+6% +$2.82M 0.07% 299
2016
Q2
$49.9M Buy
634,166
+63,096
+11% +$4.75M 0.07% 314
2016
Q1
$41.1M Sell
571,070
-140,395
-20% -$10.6M 0.05% 363
2015
Q4
$60M Sell
711,465
-6,606
-0.9% -$548K 0.08% 294
2015
Q3
$60.1M Buy
718,071
+56,208
+8% +$4.75M 0.08% 292
2015
Q2
$55.3M Buy
661,863
+83,553
+14% +$6.37M 0.06% 340
2015
Q1
$42M Buy
578,310
+149,220
+35% +$10.6M 0.05% 409
2014
Q4
$29.6M Buy
+429,090
New +$29M 0.03% 494

Other funds holding LLY

OppenheimerFunds's LLY Position: Q1 2019 in Review

OppenheimerFunds increased its Eli Lilly (LLY) stake by 336% in Q1 2019, buying an estimated $8.29M and bringing the position to 88,460 shares worth $11.5M. The position accounts for 0.01% of the portfolio, ranked #652.

OppenheimerFunds first reported a position in LLY in Q4 2014 and has held it in 18 quarters since. The position peaked at $60.1M in Q3 2015. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • OppenheimerFunds held 88,460 shares of Eli Lilly worth $11.5M as of Q1 2019.
  • OppenheimerFunds bought 68,180 Eli Lilly shares in Q1 2019, an estimated $8.29M.
  • Eli Lilly made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #652 holding.
  • OppenheimerFunds first reported a position in Eli Lilly in Q4 2014 and has held it in 18 quarters since.
  • OppenheimerFunds's Eli Lilly position peaked at $60.1M in Q3 2015.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.